Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
A dual-peptide research blend centered around the biology of tissue repair, cellular migration, connective-tissue remodeling, and regenerative signaling, combining two peptides investigated through different areas of repair and recovery research.
BPC-157 is a synthetic 15-amino-acid peptide studied primarily in preclinical models involving cellular repair, vascular signaling, gastrointestinal tissue, connective tissue, and inflammatory pathways. TB-500 is a synthetic peptide associated with thymosin beta-4 research and is investigated in relation to actin biology, cellular migration, angiogenic signaling, and tissue-remodeling processes. Research involving the individual peptides does not establish that combining them produces additive or synergistic effects, and neither BPC-157 nor TB-500 is an FDA-approved medication.
Research Focus: Tissue Repair Biology • Cellular Migration • Connective Tissue • Actin Signaling • Vascular & Angiogenic Pathways • Tissue Remodeling • Regenerative Biology
A regenerative research-peptide combination for those interested in the science of cellular repair, connective-tissue biology, tissue remodeling, and the molecular signaling pathways involved in biological recovery.
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.
A dual-peptide research blend centered around the biology of tissue repair, cellular migration, connective-tissue remodeling, and regenerative signaling, combining two peptides investigated through different areas of repair and recovery research.
BPC-157 is a synthetic 15-amino-acid peptide studied primarily in preclinical models involving cellular repair, vascular signaling, gastrointestinal tissue, connective tissue, and inflammatory pathways. TB-500 is a synthetic peptide associated with thymosin beta-4 research and is investigated in relation to actin biology, cellular migration, angiogenic signaling, and tissue-remodeling processes. Research involving the individual peptides does not establish that combining them produces additive or synergistic effects, and neither BPC-157 nor TB-500 is an FDA-approved medication.
Research Focus: Tissue Repair Biology • Cellular Migration • Connective Tissue • Actin Signaling • Vascular & Angiogenic Pathways • Tissue Remodeling • Regenerative Biology
A regenerative research-peptide combination for those interested in the science of cellular repair, connective-tissue biology, tissue remodeling, and the molecular signaling pathways involved in biological recovery.
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.